UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 6, 2018
LANTHEUS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-36569 | 35-2318913 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
331 Treble Cove Road, North Billerica, MA 01862
(Address of principal executive offices) (Zip code)
Registrant’s telephone number, including area code:(978) 671-8001
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if theForm 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule14d-2(b) under the Exchange Act (17 CFR240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule13e-4(c) under the Exchange Act (17 CFR240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule12b-2 of the Securities Exchange Act of 1934(§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Item 8.01 | Other Events. |
On June 6, 2018, Lantheus Medical Imaging, Inc. (“LMI”), the operating subsidiary of Lantheus Holdings, Inc., received notice from NTP Radioisotopes (SOC) Ltd. (“NTP”) that it has instituted a temporary suspension of production operations at itsmolybdenum-99(“Mo-99”) processing facility in South Africa following a minor transgression of an Operating Technical Specification Limit during a recentMo-99 production run. NTP’s resumption of operations will depend on the approval by the South African Nuclear Regulator of NTP’s remediation efforts. As it has in similar situations in the past, LMI will work to source additionalMo-99 from its other suppliers, Institute for Radioelements in Belgium and ANSTO in Australia, during NTP’s current suspension of operations. Management is not changing its financial guidance at this time.
Safe Harbor for Forward-Looking and Cautionary Statements
This current report on Form8-K contains “forward-looking statements” as defined under U.S. federal securities laws. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to materially differ from those described in the forward-looking statements. Readers are cautioned not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements are discussed in our filings with the Securities and Exchange Commission (including those described in the Risk Factors section in our Annual Reports on Form10-K and our Quarterly Reports on Form10-Q).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LANTHEUS HOLDINGS, INC. | ||
By: | /s/ Michael P. Duffy | |
Name: Title: | Michael P. Duffy General Counsel, Secretary and Senior Vice President, Law and Public Policy |
Date: June 6, 2018